Salivary Gland Tumor Banking and Clinical Review

Overview

About this study

The purpose of establishing the salivary gland tissue biobank is to learn how to improve our ability to diagnose and treat salivary gland tumors. Specifically, we will be evaluating DNA, RNA, and protein in tumors and normal tissue/blood.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult male and female patients, over 18 years
Children male and female patients, over 14 years
Adult pregnant woman over 18 years that are undergoing surgical treatment for salivary gland diseases.
- Only patients with tumors involving the major or minor salivary glands that require surgical removal before normal delivery would be eligble for enrollement.

Exclusion Criteria:

Patients under the age of 14
Unable to give informed consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Joaquin Garcia, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Joaquin Garcia, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials